Evogene Ltd.(EVGN)

盘后0.5670-0.03-5.34%18:04 EDT

0.5990+0.0089+1.51%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
- Evogene宣布子公司Biomica旗下理性设计活菌产品BMC128联合纳武利尤单抗完成1期临床研究
  投资观察 · 06-02 19:41
  Evogene宣布子公司Biomica旗下理性设计活菌产品BMC128联合纳武利尤单抗完成1期临床研究
- Evogene接获纳斯达克最低买入价通知
  投资观察 · 04-03
  Evogene接获纳斯达克最低买入价通知
- 2024年第四季度Evogene GAAP每股收益为$0.06，或不可与$(0.72)预期相比，销售额为$161万，错失$363万预期
  财报速递 · 2025-03-06
  2024年第四季度Evogene GAAP每股收益为$0.06，或不可与$(0.72)预期相比，销售额为$161万，错失$363万预期
- Evogene Ltd.盘中异动快速上涨6.97%
  市场透视 · 2025-02-10
  Evogene Ltd.盘中异动快速上涨6.97%
- Evogene Ltd.盘中异动股价大跌5.13%
  市场透视 · 2025-02-08
  Evogene Ltd.盘中异动股价大跌5.13%
- Evogene Ltd.盘中异动早盘急速拉升5.88%报1.53美元
  市场透视 · 2025-02-06
  Evogene Ltd.盘中异动早盘急速拉升5.88%报1.53美元
- Evogene Ltd.盘中异动大幅拉升5.27%
  市场透视 · 2025-02-04
  Evogene Ltd.盘中异动大幅拉升5.27%
- Evogene Ltd.盘中异动股价大跌7.64%
  市场透视 · 2025-02-03
  Evogene Ltd.盘中异动股价大跌7.64%
- Evogene Ltd.盘中异动股价大涨5.80%
  市场透视 · 2025-01-31
  Evogene Ltd.盘中异动股价大涨5.80%
- Evogene Ltd.盘中异动急速拉升5.04%
  市场透视 · 2025-01-30
  Evogene Ltd.盘中异动急速拉升5.04%
- Evogene Ltd.盘中异动早盘大幅上涨6.49%
  市场透视 · 2025-01-29
  Evogene Ltd.盘中异动早盘大幅上涨6.49%
- Evogene Ltd.盘中异动大幅下挫7.83%报1.53美元
  市场透视 · 2025-01-28
  Evogene Ltd.盘中异动大幅下挫7.83%报1.53美元
- Evogene Ltd.盘中异动早盘股价大跌6.11%报1.69美元
  市场透视 · 2025-01-23
  Evogene Ltd.盘中异动早盘股价大跌6.11%报1.69美元
- Evogene Ltd.盘中异动早盘急速上涨5.62%报1.69美元
  市场透视 · 2025-01-16
  Evogene Ltd.盘中异动早盘急速上涨5.62%报1.69美元
- Evogene Ltd.盘中异动股价大涨5.59%
  市场透视 · 2025-01-15
  Evogene Ltd.盘中异动股价大涨5.59%
- Evogene Ltd.盘中异动股价大跌5.73%报1.48美元
  市场透视 · 2025-01-14
  Evogene Ltd.盘中异动股价大跌5.73%报1.48美元
- Evogene Ltd.盘中异动急速下挫7.53%
  市场透视 · 2025-01-11
  Evogene Ltd.盘中异动急速下挫7.53%
- Evogene Ltd.盘中异动急速跳水5.11%报1.67美元
  市场透视 · 2025-01-08
  Evogene Ltd.盘中异动急速跳水5.11%报1.67美元
- Evogene Ltd.盘中异动股价大跌5.14%报1.76美元
  市场透视 · 2025-01-08
  Evogene Ltd.盘中异动股价大跌5.14%报1.76美元
- Evogene Ltd.盘中异动快速跳水8.76%
  市场透视 · 2025-01-03
  Evogene Ltd.盘中异动快速跳水8.76%
公司概况
公司名称
Evogene Ltd.
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.evogene.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Evogene Ltd.于1999年10月10日根据以色列法律注册成立。该公司是一家计算生物学公司，利用其ChemPass AI引擎为制药和农业应用发现并优化小分子。经过战略调整，它专注于开发基于小分子的产品，并已建立药物发现和农业化学领域的合作关系。
- 05-15
  超过5%披露
  Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
  Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
- 04-13
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 03-26
  年度报告
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 03-26
  员工持股计划
  Form S-8 - Securities to be offered to employees in employee benefit plans
  Form S-8 - Securities to be offered to employees in employee benefit plans
- 2025-03-28
  员工持股计划
  Form S-8 - Securities to be offered to employees in employee benefit plans
  Form S-8 - Securities to be offered to employees in employee benefit plans
- 2025-03-27
  年度报告
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 2024-10-15
  超过5%披露
  Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
  Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 2024-09-26
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2024-09-19
  招股说明书
  Form F-1 - Registration statement for certain foreign private issuers
  Form F-1 - Registration statement for certain foreign private issuers
- 2024-03-28
  年度报告
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 2024-03-27
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2024-02-14
  超过5%披露
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
- 2023-03-30
  年度报告
  20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 2022-03-31
  年度报告
  20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 2022-02-11
  超过5%披露
  SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
  SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals

分时
5日
日
周
月

数据加载中...

最高

0.6073

今开

0.6012

量比

0.18

最低

0.5400

昨收

0.5901

换手率

8.47%

Evogene Ltd.(EVGN)

公司概况

热议股票